A real-world observational study to assess efficacy of novel fixed dose combination (Empagliflozin and Linagliptin) in Indian patients
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Empagliflozin/linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Jul 2020 New trial record
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association